Oligonucleotide Synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
Oligonucleotide Synthesis Market Dynamics: Impact Analysis
1. Attractive Opportunities in the Market
2. Increasing Use of Synthesized Oligos in Molecular Diagnostics
3. Clinical Applications
4. R&D Expenditure in Pharmaceutical and Biotechnology Companies
The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%
Key Questions Addressed in The Report:
1. Who are the top 10 players operating in the global Oligonucleotide Synthesis market?
2. What are the drivers, restraints, opportunities, and challenges in the Oligonucleotide Synthesis Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of Oligonucleotide Synthesis in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?
Therapeutic applications:
The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA & antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period. This can primarily be attributed to the investments made by companies to explore the therapeutic applications of oligos. Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA.
In 2018, these oligonucleotide-based drugs generated a revenue of ~USD 2 billion. Apart from this, there are a couple of oligonucleotide-based drugs in Phase III and FDA review, and these drugs might be launched in the next five years and may positively impact this market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350
Oligonucleotide-based drugs:
The synthesized oligos market, by product, is segmented into oligonucleotide-based drugs, primers, probes, large-scale synthesized oligos, intermediate-scale synthesized oligos, and linkers and adaptors. Of these, oligonucleotide-based accounted for over 50% of the synthesized oligos market share in 2018. This segment is also estimated to grow at the highest CAGR during the forecast period due to the increasing demand for oligonucleotide-based drugs and the influx of new customers in the oligo drug development arena.
This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
Know more about the oligonucleotide synthesis market Industry Segments, Growth, Size, Key Players Analysis.
Regional Growth Analysis of Oligonucleotide Synthesis:
The oligonucleotide synthesis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the oligonucleotide synthesis market majorly due to the availability of funds for research from various public- and private-sector organizations in the region and the focus of various prominent players on strengthening their presence in North America.
Know about the Growth Opportunities of Oligonucleotide Synthesis Market in Europe,the Asia Pacific, Latin America, and the Middle East & Africa.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350
Key Players in Market:
The prominent players operating in the oligonucleotide synthesis industry include BioAutomation Corporation (US), LGC Biosearch Technologies (US), Eurogentec (Belgium), GeneDesign, Inc. (Japan), Sarepta Therapeutics (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), GenScript, Inc. (US), Integrated DNA Technologies (IDT, US), Nitto Denko Avecia, Inc. (US), TriLink BioTechnologies (US), Biogen International (US), ATDBio Ltd. (UK), Bio-Synthesis, Inc. (US), Eurofins Genomics (Germany), GE Healthcare (US), Sigma-Aldrich Corporation (a part of Merck KGAA, US), and Sarepta Therapeutics (US).
Oligonucleotide Synthesis Market Experiencing Significant Growth in Research Activities of the Pharma and Biotech Sectors
This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, coveringGenescriptGeneArt (Thermofischer)IDTDNA 2.0 (ATUM)OriGeneBBIGenewizEurofins GenomicsGene OracleSBS GenetechBio BasicDownload FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-oligonucleotide-synthesis-2018-994On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split intoPrimersProbesIntermediate-scale Synthesis OligosLarge-scale Synthesis OligosLinkers and AdaptorsBy Application, the market can be split intoChinaUSAEuropeJapanKoreaIndiaSoutheast AsiaSouth AmericaBy Regions, this report covers (we can add the regions/countries as you want)If you have any special requirements, please let us know and we will offer you the report as you want.Get the Complete Report & TOC @ https://www.grandresearchstore.com/energy-and-natural-resources/global-oligonucleotide-synthesis-2018-994Table of content1 Report Overview1.1 Definition and Specification1.2 Report Overview1.2.1 Manufacturers Overview1.2.2 Regions Overview1.2.3 Type Overview1.2.4 Application Overview1.3 Industrial Chain1.3.1 Oligonucleotide Synthesis Overall Industrial Chain1.3.2 Upstream1.3.3 Downstream1.4 Industry Situation1.4.1 Industrial Policy1.4.2 Product Preference1.4.3 Economic/Political Environment1.5 SWOT Analysis2 Market Analysis by Types2.1 Overall Market Performance(Volume)2.1.1 Primers Market Performance (Volume)2.1.2 Probes Market Performance (Volume)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Volume)2.1.4 Large-scale Synthesis Oligos Market Performance (Volume)2.1.5 Linkers and Adaptors Market Performance (Volume)2.2 Overall Market Performance(Value)2.1.1 Primers Market Performance (Value)2.1.2 Probes Market Performance (Value)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Value)2.1.4 Large-scale Synthesis Oligos Market Performance (Value)2.1.5 Linkers and Adaptors Market Performance (Value)3 Product Application Market3.1 Overall Market Performance (Volume)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
Furthermore, the information for these segments, by region, is also presented in this report.
Revenue Growth Analysis: [246 Pages Report] The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 Key Factors Driving Market Growth: The major factors driving the growth of this market include the increasing use of synthesized oligos in therapeutic applications, increasing government funding, and the growing focus on personalized medicine.
Increasing government investments for synthetic biology and genome projects In recent years, governments in various countries have made significant investments in projects related to the field of synthetic biology and genomics.
Some focus areas of this project are precision health, rare genetic disorders, mutation spectrum of genetic & complex diseases in the Indian population, genetic epidemiology of multifactorial lifestyle diseases, and translational research.
In September 2019, a whole-genome sequencing project of USD 224 million was created, forming a partnership of pharmaceutical firms and health experts, which will examine and sequence the genetic code of 500,000 volunteers at the UK Biobank, based in Stockport, UK.
This report focuses on top manufacturers in global market, with Sales, price, revenue and market share for each manufacturer, coveringGenescriptGeneArt (Thermofischer)IDTDNA 2.0 (ATUM)OriGeneBBIGenewizEurofins GenomicsGene OracleSBS GenetechBio BasicDownload FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-oligonucleotide-synthesis-2018-994On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split intoPrimersProbesIntermediate-scale Synthesis OligosLarge-scale Synthesis OligosLinkers and AdaptorsBy Application, the market can be split intoChinaUSAEuropeJapanKoreaIndiaSoutheast AsiaSouth AmericaBy Regions, this report covers (we can add the regions/countries as you want)If you have any special requirements, please let us know and we will offer you the report as you want.Get the Complete Report & TOC @ https://www.grandresearchstore.com/energy-and-natural-resources/global-oligonucleotide-synthesis-2018-994Table of content1 Report Overview1.1 Definition and Specification1.2 Report Overview1.2.1 Manufacturers Overview1.2.2 Regions Overview1.2.3 Type Overview1.2.4 Application Overview1.3 Industrial Chain1.3.1 Oligonucleotide Synthesis Overall Industrial Chain1.3.2 Upstream1.3.3 Downstream1.4 Industry Situation1.4.1 Industrial Policy1.4.2 Product Preference1.4.3 Economic/Political Environment1.5 SWOT Analysis2 Market Analysis by Types2.1 Overall Market Performance(Volume)2.1.1 Primers Market Performance (Volume)2.1.2 Probes Market Performance (Volume)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Volume)2.1.4 Large-scale Synthesis Oligos Market Performance (Volume)2.1.5 Linkers and Adaptors Market Performance (Volume)2.2 Overall Market Performance(Value)2.1.1 Primers Market Performance (Value)2.1.2 Probes Market Performance (Value)2.1.3 Intermediate-scale Synthesis Oligos Market Performance (Value)2.1.4 Large-scale Synthesis Oligos Market Performance (Value)2.1.5 Linkers and Adaptors Market Performance (Value)3 Product Application Market3.1 Overall Market Performance (Volume)CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
Furthermore, the information for these segments, by region, is also presented in this report.
Revenue Growth Analysis: [246 Pages Report] The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 Key Factors Driving Market Growth: The major factors driving the growth of this market include the increasing use of synthesized oligos in therapeutic applications, increasing government funding, and the growing focus on personalized medicine.
Increasing government investments for synthetic biology and genome projects In recent years, governments in various countries have made significant investments in projects related to the field of synthetic biology and genomics.
Some focus areas of this project are precision health, rare genetic disorders, mutation spectrum of genetic & complex diseases in the Indian population, genetic epidemiology of multifactorial lifestyle diseases, and translational research.
In September 2019, a whole-genome sequencing project of USD 224 million was created, forming a partnership of pharmaceutical firms and health experts, which will examine and sequence the genetic code of 500,000 volunteers at the UK Biobank, based in Stockport, UK.